Regenetech, Inc.

Regenetech is focused on extraction, expansion and reimplantation of autologous adult stems cells.

Regenetech was founded in 2002 as BioCell Innovations. In November 2002 the company changed its name into Regenetech. Regenetech’s core technology was developed at NASA during the last 20 years. Today the company works with the NASA under its license and Reimbursable Space Act Agreement.

David Bonner, PhD, Chairman and CEO
Donnie Rudd, Chief Scientist
Jim Rogers, CFO
Francesca Vitelli, PhD, Technology Director
Anita Beneke, MD, CMO

Glen Odom
Kyle Shanks
H. Lee Murphy III
David C. Bonner, PhD
C. James Rogers
Donnie Rud
Larry Brown
Jack Hill
Paul Viallon IV

David Wu, PhD
David Wolf, MD
Mehboob Hussain, MD
obert Dennis, PhD
Richard Willson, PhD
Mark Labbé, MD

2801 Post Oak Blvd.
Suite 180
Houston
TX 77056
USA

Phone: +1-713-212-0671
Fax: +1-713-456-2769

Regenetech uses the patented Intrifuge™ system process to expand adult stem cells. The technology, originally discovered in space shuttle experiments, is a method of growing stem cells three-dimensionally (3D) in a simulated weightless environment (cellXpansion™).

Regenetech owns the license to several NASA patents and possesses 30 additional patent applications of its own. A selection of Regenetech’s patents are listed below.

For comprehensive patent information please refer to the espacenet databases.